Detalles de la búsqueda
1.
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.
Cell Mol Biol Lett
; 29(1): 71, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745155
2.
The Influence of Bacteriophages on the Metabolic Condition of Human Fibroblasts in Light of the Safety of Phage Therapy in Staphylococcal Skin Infections.
Int J Mol Sci
; 24(6)2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983034
3.
Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine Derivatives with Pro-Apoptotic Activity against Cancer Cells.
Int J Mol Sci
; 24(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36901869
4.
The Cooperative Anti-Neoplastic Activity of Polyphenolic Phytochemicals on Human T-Cell Acute Lymphoblastic Leukemia Cell Line MOLT-4 In Vitro.
Int J Mol Sci
; 23(9)2022 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563141
5.
Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluation.
Bioorg Chem
; 104: 104309, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33011532
6.
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics.
Cancer Immunol Immunother
; 68(4): 587-598, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725204
7.
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients.
Int J Mol Sci
; 20(8)2019 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30995757
8.
Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
J Clin Immunol
; 36(5): 517-27, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27146825
9.
Gain-of-function mutation in complement C2 protein identified in a patient with aHUS.
J Allergy Clin Immunol
; 146(4): 916-919.e11, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32113979
10.
Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability.
Molecules
; 21(6)2016 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27338337
11.
Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanism.
Transl Res
; 269: 1-13, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395390
12.
Parameters critical for the effector mechanism of anti-CD20 antibodies revisited.
Br J Haematol
; 180(6): 777-779, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29411875
13.
U937 variant cells as a model of apoptosis without cell disintegration.
Cell Mol Biol Lett
; 18(2): 249-62, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23605997
14.
The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab.
Cancers (Basel)
; 16(1)2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201478
15.
Induction of apoptosis in HL-60 cells through the ROS-mediated mitochondrial pathway by ramentaceone from Drosera aliciae.
J Nat Prod
; 75(1): 9-14, 2012 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22250825
16.
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies.
Cancers (Basel)
; 14(5)2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267578
17.
A tale of the monoclonal anti-CD20 antibodies, in tribute to prof. Waclaw Szybalski (1921-2020).
Acta Biochim Pol
; 68(3): 353-358, 2021 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463467
18.
Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein.
Front Immunol
; 12: 724361, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34899688
19.
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies.
J Immunol Methods
; 476: 112675, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629742
20.
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.
Front Immunol
; 11: 584509, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329558